MENU

EVMN

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Evommune (EVMN) Ownership - Who owns Evommune?

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

812.21M

P/E Ratio

N/A

Total Cash

211.46M

Projected Growth

N/A

Total Debt

8.55M

Revenue

10M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

5.87

Total Debt/Equity

N/A

Revenue/Share

0.28 USD as % of share price

View a ticker or compare two or three

VS

VS

EVMN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for EVMN

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details